Components Components Results Results OPKO ALGORITHM What is the 4Kscore Test? + Age, DRE, and prior biopsy status % risk of having aggressive prostate cancer for an individual patient OPKO { 4 kallikrein levels: Total PSA Free PSA Intact PSA hK2
Slide 4
Slide 5: Prostate cancer screening and biopsy pathway
Monitor w PSA or PCA3, ConfirmMDx Monitor w PSA or PCA3, ConfirmMDx 100,000 Standard TRUS or mp MRI-Guided Biopsy 100,000 Standard TRUS or mp MRI-Guided Biopsy Negative Biopsy Histopathology Negative Biopsy Histopathology Biopsy Result Biopsy Result Primary Treatment Surgery / Radiation Primary Trea
Slide 6: 4Kscore pathway: biopsy reduction and savings
Monitor w PSA if abnormal, 4Kscore Monitor w PSA if abnormal, 4Kscore Biopsy Result Biopsy Result Primary Treatment Surgery / Radiation Primary Treatment Surgery / Radiation Active Surveillance Active Surveillance Primary Treatment Surgery / Radiation Primary Treatment Surgery / Radiation Negative B
Slide 7: The 4Kscore Test Predicts Metastases Within Years
The 4Kscore Test Predicts Metastases Within years 16% < 2% 4Kscore Test > 7.5% 4Kscore Test 7.5% ¹ Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case–Control Study European Urology (in press)
Slide 8: Claros 1: Rapid Testing in the Physician Office